Stocks · Health care · Biological Products, (No Diagnostic Substances)

CG Oncology, Inc.

CGON Clue Score59
United States Fiscal year ends December CIK 0001991792 Results filed 6 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Brian Guan-Chyun Liu
25 Jun 2026
Director
Buy indirect
371,085
$66.87
$24.81M
Brian Guan-Chyun Liu
11 Sep 2025
Director
Buy indirect
1,515,151
$33.00
$50.00M
Decheng Capital Global Life Sciences Fund IV, L.P.
29 Jan 2024
10% owner
Buy indirect
400,000
$19.00
$7.60M
Hong Fang Song
29 Jan 2024
Director
Buy
263,157
$19.00
$5.00M
Corleen M. Roche
29 Jan 2024
CFO & Secretary
Buy
2,000
$19.00
$38.00K
Vijay Kasturi
29 Jan 2024
Chief Medical Officer
Buy
1,315
$19.00
$24.99K

What was left out

Form 4 filings counted 76
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 38
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 9,248,735
History held since 26 Jan 2024